eJHaem (Jul 2020)

Use of obinutuzumab for refractory autoimmune thrombocytopenia secondary to CLL

Rohitashva Agrawal,
Reinhold Munker,
Maxwell M. Krem

Affiliations

Rohitashva Agrawal: Division of Hematology and Blood & Marrow Transplantation Markey Cancer Center University of Kentucky College of Medicine Lexington Kentucky
Reinhold Munker: Division of Hematology and Blood & Marrow Transplantation Markey Cancer Center University of Kentucky College of Medicine Lexington Kentucky
Maxwell M. Krem: Division of Hematology and Blood & Marrow Transplantation Markey Cancer Center University of Kentucky College of Medicine Lexington Kentucky

DOI: https://doi.org/10.1002/jha2.78
Journal volume & issue: Vol. 1, no. 1
pp. 368 – 370

Abstract

No abstracts available.

Published in eJHaem

ISSN: 2688-6146 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
Website: https://onlinelibrary.wiley.com/journal/26886146

About the journal